Martine Rothblatt Ph.D., J.D., M.B.A. United Therapeutics Corporation CEO Rating

United Therapeutics Corporation CEO Martine Rothblatt Ph.D., J.D., M.B.A. Bio

Dr. Martine A. Rothblatt, Ph.D., J.D., M.B.A., founded United Therapeutics Corporation in 1996 and has been its Chief Executive Officer since June 26, 2016 and as its Chairman since 1996. Dr. Rothblatt serves as the Chairman, President and Chief Executive Officer of Lung Rx Inc (also known as Lung LLC). Dr. Rothblatt served as Co-Chief Executive Officer of United Therapeutics Corporation from January 1, 2015 to June 26, 2016. Dr. Rothblatt served as the Chief Executive Officer of United Therapeutics Corporation from 1996 to January 2015. She is a communications technologist and medical biotechnology executive. Prior to founding United Therapeutics, she founded and served as Chief Executive Officer of Sirius Satellite Radio, co-founded and served as Chief Operating Officer of satellite sound broadcasting pioneer WorldSpace Corp. and was principally responsible for several other unique applications of satellite communications technology. Dr. Rothblatt also represented the radio astronomy interests of the National Academy of Sciences Committee on Radio Frequencies before the FCC and led the International Bar Associations efforts to present the United Nations with a draft Human Genome Treaty. She is a member of the Committee on Science, Technology and Law of the National Academy of Sciences. She serves as Director of Synthetic Genomics, Inc. Dr. Rothblatt serves as the President of the William Harvey Medical Research Foundation and past-Chairman of the Law and Medicine Committee of the International Bar Association. Her book, Your Life or Mine: How Geoethics Can Resolve the Conflict Between Public and Private Interests In Xenotransplantation was published by Ashgate in 2004. Dr. Rothblatt graduated from UCLA with a combined law and MBA degree in 1981 and received her Ph.D. in Medical Ethics in 2001 from University of London.

United Therapeutics Corporation CEO Martine Rothblatt Ph.D., J.D., M.B.A. At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at United Therapeutics Corporation.

Overall, the CEO score has remained stable over the last 90 days.